Quarterly ResultAug 11, 2026, 06:52 AM
Cardinal Health Q4 Revenue $63.7B, FY26 EPS $11.26; FY27 Guidance
AI Summary
Cardinal Health reported strong fourth quarter and fiscal year 2026 results, with Q4 revenue up 6% to $63.7 billion and non-GAAP diluted EPS increasing 40% to $2.91. For the full fiscal year 2026, revenues rose 14% to $254.2 billion, and non-GAAP diluted EPS grew 37% to $11.26. The company also provided positive fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60, reflecting 13% to 15% growth, and announced a $5.0 billion increase to its share repurchase authorization.
Key Highlights
- Fourth quarter revenue increased 6% to $63.7 billion.
- Fourth quarter non-GAAP diluted EPS increased 40% to $2.91.
- Fiscal year 2026 revenues were $254.2 billion, a 14% increase.
- Fiscal year 2026 non-GAAP diluted EPS increased 37% to $11.26.
- Fiscal year 2026 operating cash flow was $5.2 billion and adjusted free cash flow was $5.0 billion.
- Board approved a $5.0 billion increase to the share repurchase program.
- Fiscal year 2027 non-GAAP EPS guidance is $12.40 to $12.60, representing 13% to 15% growth.
- Declared a quarterly dividend of $0.5158 per share, payable October 15, 2026.
Price Impact
More from CAH